Skip to content
The Nexus
DossierENTITY

James Fleckenstein

Coverage of James Fleckenstein in the Nexus archive.

Earliest in view: Jul 6 · 23:57 UTCMost recent: Jul 6 · 23:57 UTC
Co-mentioned in this coverage
Valnevaorganization1University of Bergenorganization1Norwegian Research Centerorganization1enterotoxigenic Escherichia colitopic1Washington University School of Medicine in St. Louisorganization1
Recent coverage
  • HEALTHJul 6 · 23:57 UTCFOX NEWS
    Experimental vaccine shows promise against dangerous intestinal illness

    An experimental vaccine targeting enterotoxigenic Escherichia coli (ETEC), a major cause of severe diarrhea, has reached a development milestone and was licensed to Valneva. Researchers at the University of Bergen and Norwegian Research Center (NORCE) developed the technology, which shows promise in eliciting protective immune responses in children. The vaccine remains in development, requiring further trials and regulatory approval before public availability.

James Fleckenstein · Dossier · The Nexus